StockWatch
·

KABRA DRUGS LTD. Q1 FY26 Results

KABRADGQ1 FY26 Results
Filing
MetricValue ( Cr)vs Q4 FY25
Revenue7.15
Total Income7.171019.4%
Expenditure7.672997.4%
PBT-0.50227.3%
Net Profit-0.50227.0%
OPM-7.17%
NPM-6.98%68.48pp
EPS0.210.0%
View full financials

Informational and educational content only. Not investment advice.